Evaluation of Computed Tomography, Clinical and Laboratory Findings of COVID-19 in Cancer Patients

Basit Öğe Kaydı
dc.contributor.authorKöşeci, Tolga
dc.contributor.authorKaya, Ömer
dc.contributor.authorDilek, Okan
dc.contributor.authorAlişan, İrfan
dc.contributor.authorÇil, Timuçin
dc.contributor.authorDuman, Berna Bozkurt
dc.contributor.authorHaksöyler, Veysel
dc.date.accessioned2023-04-10T20:19:33Z
dc.date.available2023-04-10T20:19:33Z
dc.date.issued2020
dc.departmentRektörlük, Rektörlüğe Bağlı Birimler, Düzce Üniversitesi Dergilerien_US
dc.description.abstractAim: The aim of this study was to evaluate the computed tomography (CT), clinical andlaboratory findings of coronavirus disease 2019 (COVID-19) in cancer patients and to comparethe findings between polymerase chain reaction (PCR) positive and negative patients.Material and Methods: Twenty-three cancer patients with positive PCR tests and 22diagnosed as COVID-19 with clinical and radiological findings were included in the study. CTimages of the patients were evaluated simultaneously by two radiologists. Presence ofcomorbid diseases, symptoms and laboratory values were evaluated.Results: The most common CT involvement pattern was peripheral with 88.9% (n=40).Bilateral lung involvement rate was 57.8% (n=26). The most common finding was groundglass opacities (n=38, 84.5%). 35.6% (n=16) of these were accompanied by consolidation.Multifocal involvement was present in 62.2% (n=28) of the cases. The most frequentlyinvolved lobes were lower lobes. Other relatively common findings were septal thickening,subpleural streaking, and air bronchogram. The median neutrophil, lymphocyte, D-dimer,procalcitonin, C-reactive protein and lactate dehydrogenase values of the patients were 2000mm3, 1200 mm3, 1990 ng/mL, 30.7 mcg/L 15.8 mg/dl, 161 IU/L, respectively.Conclusion: Multifocal and bilateral involvement, and ground glass opacities were the mostcommon findings. However, higher rates of septal thickening, which is generally less common,suggest that the findings may be more severe in cancer patients. Most of the inflammatorymarkers were higher in PCR negative cases. Studies with more patients in multiple centers willprovide better comparison of the findings in cancer patients with the general population.en_US
dc.identifier.doi10.18678/dtfd.795333
dc.identifier.endpage60en_US
dc.identifier.issn1307-671X
dc.identifier.issueS1en_US
dc.identifier.startpage56en_US
dc.identifier.trdizinid386585en_US
dc.identifier.urihttp://doi.org/10.18678/dtfd.795333
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/386585
dc.identifier.urihttps://hdl.handle.net/20.500.12684/11411
dc.identifier.volume22en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofDüzce Tıp Fakültesi Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleEvaluation of Computed Tomography, Clinical and Laboratory Findings of COVID-19 in Cancer Patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
11411.pdf
Boyut:
386.77 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
Düzce Tıp Fakültesi Dergisi Koleksiyonu